Urinary tract infection (UTI) is very common in children. The future of kidney function depends on its management. Our objective was to investigate the epidemio-clinical, bacteriological and therapeutic profile of UTIsin the Pediatric Department of Tamatave University Hospital Center, Madagascar for better care of children. Methods: This is a retrospective and descriptive study that was carried out in the Pediatrics Department of Tamatave University Hospital over a three-year period from January 1, 2017 to December 31, 2019. The parameters retained and studied were age, gender, clinical signs, pathogens identified with the results of the antibiotic susceptibility tests and the treatments received. Results: The frequency of UTI was 7.46%. The average age was 11.21 months, with extremes of 2 to 120 months. Fever was the main symptom found (80.95%) followed by urinary signs. Escherichia coli was the most frequently isolated bacteria (61.90%). Almost all of the isolates found (98%) were resistant to amoxicillin, tetracycline and cotrimoxazole. Ceftriaxone alone was the most used (44.44%). Discussion: This study suggests that gentamicin and ceftriaxone (even though ESBLs were found) should be included in the treatment protocol for UTIs in the absence of an antibiogram, which is not always available in our context.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.